Johns Hopkins and Eisai Extend Drug Discovery Collaboration with New Licensing Agreement

The Johns Hopkins University and Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo, Japan-based Eisai Co., Ltd., announced today that they have extended their drug discovery collaboration through an exclusive licensing agreement.


Current News Releases

Submit comment

Allowed HTML tags: <a href="http://google.com">google</a> <strong>bold</strong> <em>emphasized</em> <code>code</code> <blockquote>
quote
</blockquote>